News

Here’s what to know about the twice-yearly preventative HIV shot - A twice-yearly drug called lenacapavir is now the ...
The FDA has approved Yeztugo, the first long-acting injectable PrEP shot, which could significantly impact HIV prevention ...
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
In Shelby County, which is one of the largest HIV transmission areas in the country according to a 2024 study, people looking ...
The U.S. has just approved a powerful new weapon in the fight against HIV: a twice-a-year prevention shot called Yeztugo. Made by Gilead Sciences, the injectable treatment slashes the risk […] The ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The at-home test is billed as a non-invasive alternative to hormonal birth control methods — and early tests have shown ...
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
The test, which uses saliva to track a hormone that plays a role in fertility, is expected to roll out across Europe this ...